| 产品名称 |
(8S,10S,13S,14S,16S)-17-(1,3,6,8-Tetraoxaspiro[4.4]nonane)-10,13,16-trimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one from UNITED STATES BIOLOGICAL |
| 产品详情 |
| Edit |   |
| Product Name | (8S,10S,13S,14S,16S)-17-(1,3,6,8-Tetraoxaspiro[4.4]nonane)-10,13,16-trimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one |
| Description | (8S,10S,13S,14S,16S)-17-(1,3,6,8-Tetraoxaspiro[4.4]nonane)-10,13,16-trimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one is an intermediate in the synthesis of 16β-Methyl-17α,21-Dihydroxypregna-1,4-diene-3,20-dione (M302195). 16β-Methyl-17α-Dihydroxypregna-1,4-diene-3,20-dione is an intermediate in the synthesis of 17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione (D434280), a corticoid with the potential for ant-inflammatory activity. Molecular Formula: C24H30O5 Solubility: Dichloromethane, Ethyl Acetate Molecular Weight: 398.49 |
| Size | 10mg, 25mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | 440271 |
| Price | |
| Order / More Info | (8S,10S,13S,14S,16S)-17-(1,3,6,8-Tetraoxaspiro[4.4]nonane)-10,13,16-trimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|